Business Model

BioQuest’s business model focuses on accelerating value creation by reducing development timelines of promising new medical technologies while minimizing investment requirements. The BioQuest model leverages the commercial and scientific expertise provided by our management team and expertly integrates additional skills and capabilities across a broad range of functions and disciplines as required. The BioQuest team works with emerging biotech companies, technology transfer offices, and inventors in mutually beneficial arrangements that allow all parties to achieve their goals as quickly as possible.

• We actively manage to accelerate development timelines.
• We focus on the primary opportunity or lead indication for each technology.
• We employ a virtual business model, and we share resources across multiple programs and companies to minimize costs.

Strategy

Our strategy concentrates on the keys to building a successful biotech company.

We focus on:

• Achieving corporate milestones
• Validating product portfolios
• Facilitating access to money

We excel at:

• Managing risk
• Integrating skills and capabilities across a broad range of disciplines and functions; and
• Effectively advancing critical knowledge

Critical Path

The critical path of BioQuest’s value creation model includes:

• Identification of promising early-stage therapeutics, devices and diagnostics from universities, research institutes, and biotech companies
• Screen and validate the technology
• Raise seed funding / secure financing
• License the technology into a newly created corporation if appropriate
• Assemble experienced management team and Board of Directors
• Develop preclinical and Phase I development plan
• Prepare company to secure financing or for IPO
• Engage CMO to produce material
• Engage CROs to conduct pre-clinical and Phase I studies
• Drive development of technology
• Facilitate out-licensing or acquisition deals for the company, targeted for 18-24 months

BioQuest Innovations' Business Model